Ezcol Overview

  • Founded
  • 2007
  • Status
  • Private
  • Latest Deal Type
  • Angel
  • Investors
  • 1

Ezcol General Information


Developer of an innovative drug designed to lower cholesterol. The company's cholesterol-diminishing bacterium keeps cholesterol in check, enabling patients to reduce the risk of heart disease and strokes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • Lunerkampweg
  • 5245 NB Hertogenbosch
  • Netherlands
+31 073 000 0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Ezcol Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Angel (individual) 01-Mar-2020 Completed Generating Revenue
1. Accelerator/Incubator 30-Nov-2008 Completed Generating Revenue
To view Ezcol’s complete valuation and funding history, request access »

Ezcol Executive Team (2)

Name Title Board Seat Contact Info
Rob Suters Co-Founder & Chief Executive Officer
To view Ezcol’s complete executive team members history, request access »

Ezcol Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
ESA Space Solutions Accelerator/Incubator Minority 000 0000 000000 0
To view Ezcol’s complete investors history, request access »